Latest Breaking News On - Intas pharmaceuticals - Page 7 : comparemela.com

Accord s aBLA for Proposed Biosimilar DMB-3115 Accepted by FDA | Venable LLP

According to a January 2024 press release from Accord BioPharma, Inc. (“Accord”), the FDA accepted Accord’s abbreviated Biologics License Application (aBLA) for DMB-3115 (ustekinumab),.

United statesA johnsonApril breyer menonSeika pharmaAccord biopharma incDonga socio holdingsIntas pharmaceuticalsAccord biopharmaBiologics license applicationJanssen biotechMeiji seika pharma

Global Pegfilgrastim Biosimilar Market Analysis (2019 - 2030)

Global Pegfilgrastim Biosimilar Market Analysis (2019 - 2030)

United statesSouth africaPegfilgrastim biosimilarParmeet singhAsia pacificCoherus biosciencesDhirtek business researchMundipharma internationalConsulting privateIntas pharmaceuticalsSample reportHospital pharmaciesMail order pharmaciesRetail pharmaciesNorth americaLatin america

Abu Dhabi s Mubadala-backed firm to invest in top Indian healthcare facility

Abu Dhabi s Mubadala-backed firm to invest in top Indian healthcare facility
zawya.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from zawya.com Daily Mail and Mail on Sunday newspapers.

Abu dhabiAbuz abyUnited arab emiratesSeban scariaRamsay sime darbyBindu raiMalaysia employees provident fundHong leong groupAbu dhabi investment authorityCompetition commission of indiaAbu seventy second investment companyMubadala mamoura diversified global holdingManipal health enterprisesIntas pharmaceuticalsMamoura diversified global holdingCompetition commission

Abu Dhabi s Mubadala-backed firm to invest in top Indian healthcare facility

Abu dhabiAbuz abyUnited arab emiratesRamsay sime darbyBindu raiSeban scariaHong leong groupManipal health enterprisesMubadala mamoura diversified global holdingMalaysia employees provident fundAbu seventy second investment companyAbu dhabi investment authorityIntas pharmaceuticalsCompetition commission of indiaMamoura diversified global holdingCompetition commission

DelveInsight Business Research, LLP: AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032)

DelveInsight Business Research, LLP: AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesOlenasufligene relduparvovecRoche pharmaGensight biologicsNeurotherapy bioMeira gtxShruti thakurAstellas pharmaScout bioUniqure biopharmaPrnewswire delveinsightChiesi farmaceuticiEli lillyCapsida biotherapeuticsSelecta biosciencesBridgebio pharma